相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes
Agnes Benardeau et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
Robert R. Henry et al.
LANCET (2009)
Benefit of adding pioglitazone to successful statin therapy in nondiabetic patients with coronary artery disease
Koichi Sugamura et al.
CIRCULATION JOURNAL (2008)
Interaction of oral antidiabetic drugs with hepatic uptake transporters -: Focus on organic anion transporting polypeptides and organic cation transporter 1
Louri Bachmakov et al.
DIABETES (2008)
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk
Thomas Forst et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: A randomized, open-label, three-way crossover study
Yunxia Li et al.
CLINICAL THERAPEUTICS (2007)
ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid
Theunis C. Goosen et al.
DRUG METABOLISM AND DISPOSITION (2007)
Safety of Rosuvastatin: Update on 16,876 Rosuvastatin-Treated Patients in a Multinational Clinical Trial Program
James Shepherd et al.
CARDIOLOGY (2007)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
Theodore Mazzone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Comparative safety of Atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients
C Newman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport
M Yamazaki et al.
XENOBIOTICA (2005)
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2004)
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial
AJ Lewin et al.
CLINICAL THERAPEUTICS (2004)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes
JS Wang et al.
DRUG METABOLISM AND DISPOSITION (2002)